
Novocure Ltd
NASDAQ:NVCR

Intrinsic Value
The intrinsic value of one
NVCR
stock under the Base Case scenario is
28.8
USD.
Compared to the current market price of 17.73 USD,
Novocure Ltd
is
Undervalued by 38%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Novocure Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Novocure Ltd
Balance Sheet Decomposition
Novocure Ltd
Current Assets | 1.1B |
Cash & Short-Term Investments | 959.9m |
Receivables | 109.3m |
Other Current Assets | 37.4m |
Non-Current Assets | 134.2m |
PP&E | 119.6m |
Other Non-Current Assets | 14.6m |
Free Cash Flow Analysis
Novocure Ltd
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Novocure Ltd
Revenue
|
605.2m
USD
|
Cost of Revenue
|
-137.1m
USD
|
Gross Profit
|
468.1m
USD
|
Operating Expenses
|
-636.6m
USD
|
Operating Income
|
-168.5m
USD
|
Other Expenses
|
-134k
USD
|
Net Income
|
-168.6m
USD
|
NVCR Profitability Score
Profitability Due Diligence
Novocure Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Score
Novocure Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
NVCR Solvency Score
Solvency Due Diligence
Novocure Ltd's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Score
Novocure Ltd's solvency score is 34/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NVCR Price Targets Summary
Novocure Ltd
According to Wall Street analysts, the average 1-year price target for
NVCR
is 36.28 USD
with a low forecast of 29.29 USD and a high forecast of 44.1 USD.
Dividends
Current shareholder yield for NVCR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
NVCR
stock under the Base Case scenario is
28.8
USD.
Compared to the current market price of 17.73 USD,
Novocure Ltd
is
Undervalued by 38%.